PDL BioPharma up for sale

PDL BioPharma Inc. (PDL) is actively seeking offers for the sale of the company as a whole or of its key assets following a review of its strategic alternatives.

In conjunction with the announcement of the potential sale on Monday, CEO and director Mark McDade also stepped down immediately. The company’s board elected former chairperson of the board L. Patrick Gage as interim CEO and Karen A. Dawes as the new chairperson of the board.

The company has said it is relocating from Fremont to Redwood City this fall.

Norooz Spring Festival kicks off Persian New Year celebrations

People gathered in Union Square Saturday, March 9, 2019 to commence Persian New Year Celebrations. Norooz (also spelled Nowruz) takes…

By Examiner Staff
Breaking: University of San Francisco promotes Joan McDermott to athletic director

The University of San Francisco has found its next athletic director. The Dons have decided to promote Joan McDermott, the…

By Ryan Gorcey
Arrest made in ‘motorcycle bandit’ robberies

An arrest has been made in connection with a series of armed robberies in December and January that police dubbed…

By Victor Tence